Myrbetriq - mirabegron
Navigation: NDC > Supplier starting with: A > ASTELLAS PHARMA US, INC.| Field | Value |
|---|---|
| NDC Code: | 0469-2602 |
| Proprietary Name: | Myrbetriq |
| Suffix: | |
| Non-Proprietary Name: | mirabegron |
| Dosage Form: | TABLET, FILM COATED, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 28-06-2012 |
| Category Name: | NDA |
| Application Number: | NDA202611 |
| Labeler: | ASTELLAS PHARMA US, INC. |
| Substance Name: | MIRABEGRON |
| Active Numerator Strength: | 50 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| DEA Schedule: |